Cardiac and skeletal muscle development in P19 embryonal carcinoma cells

Trends in Cardiovascular Medicine

Volumn 9, Issue 5, 1999, Pages 139-143

  Skerjanc, Ilona S ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ANIMAL CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONAL CARCINOMA; GENE LOSS; GENE OVEREXPRESSION; GENETIC MANIPULATION; HEART MUSCLE; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

ANIMALS; CARCINOMA, EMBRYONAL; CELL AGGREGATION; CELL DIFFERENTIATION; DIMETHYL SULFOXIDE; GENE EXPRESSION REGULATION; MESODERM; MICE; MUSCLE PROTEINS; MUSCLES; MYOCARDIUM; TERATOMA; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0033461171     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(99)00017-1     Document Type: Review

References (39)

1. Angello J.C., Stern H.M., Hauschka S.D. P19 embryonal carcinoma cells. a model system for studying neural tube induction of skeletal myogenesis Dev Biol. 192:1997;93-98.
2. Armour C., Garson K., McBurney M.W. Cell-cell interaction modulates myoD-induced skeletal myogenesis of pluripotent P19 cells in vitro. Exp Cell Res. 251:1999;79-91.
3. Arnold H.H., Winter B. Muscle differentiation. more complexity to the network of myogenic regulators Curr Opin Genet Dev. 8:1998;539-544. [in process citation].
4. Bain G., Ray W.J., Yao M.et al. From embryonal carcinoma cells to neurons. the P19 pathway Bioessays. 16:1994;343-348.
5. Boer P.H. Activation of the gene for atrial natriuretic factor during in vitro cardiac myogenesis by P19 embryonal carcinoma cells. Exp Cell Res. 207:1993;421-429.
6. Boer P.H. Activation of the gene for type-b natriuretic factor in mouse stem cell cultures induced for cardiac myogenesis. Biochem Biophys Res Commun. 199:1994;954-961.
7. Currie P.D., Ingham P.W. The generation and interpretation of positional information within the vertebrate myotome. Mech Dev. 73:1998;3-21.
8. Durocher D., Grepin C., Nemer M. Regulation of gene expression in the endocrine heart. Recent Prog Horm Res. 53:1998;7-23.
9. Gossler A, Hrabe de Angelis M: 1998. Somitogenesis. In Pederson RA, Schatten GP, eds. Current Topics in Developmental Biology. Vol. 38. Toronto, Academic Press, pp. 225-287.
10. Grepin C., Nemer G., Nemer M. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development. 124:1997;2387-2395.
11. Grepin C., Robitaille L., Antakly T.et al. Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol Cell Biol. 15:1995;4095-4102.
12. Hoodless P.A., Wrana J.L. Mechanism and function of signaling by the TGF beta superfamily. Curr Top Microbiol Immunol. 228:1998;235-272.
13. Lipskaia L., Grepin C., Defer N.et al. Adenylyl cyclase activity and gene expression during mesodermal differentiation of the P19 embryonal carcinoma cells. J Cell Physiol. 176:1998;50-56. [in process citation].
14. Macias-Silva M., Hoodless P.A., Tang S.J.et al. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem. 273:1998;25,628-25,636.
15. Maroto M., Reshef R., Munsterberg A.E.et al. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell. 89:1997;139-148.
16. McBurney M.W. P19 embryonal carcinoma cells. Int J Dev Biol. 37:1993;135-140.
17. McBurney M.W., Jones-Villeneuve E.M., Edwards M.K.et al. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature. 299:1982;165-167.
18. Molkentin J.D., Olson E.N. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA. 93:1996;9366-9373.
19. Monge J.C., Stewart D.J., Cernacek P. Differentiation of embryonal carcinoma cells to a neural or cardiomyocyte lineage is associated with selective expression of endothelin receptors. J Biol Chem. 270:1995;15385-15390.
20. Monzen K., Shiojima I., Hiroi Y., Kudoh S., Oka T., Takimoto E., Hayashi D., Hosoda T., Habara-Ohkubo A., Nakaoka T., Fujita T., Yazaki Y., Komuro I. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol Cell Biol. 19:1999;7096-7105.
21. Morley P., Whitfield J.F. The differentiation inducer, dimethyl sulfoxide, transiently increases the intracellular calcium ion concentration in various cell types. J Cell Physiol. 156:1993;219-225.
22. Natoli T.A., Ellsworth M.K., Wu C.et al. Positive and negative DNA sequence elements are required to establish the pattern of Pax3 expression. Development. 124:1997;617-626.
23. Papaioannou V.E., Silver L.M. The T-box gene family. Bioessays. 20:1998;9-19.
24. Pruitt S.C., Natoli T.A. Inhibition of differentiation by leukemia inhibitory factor distinguishes two induction pathways in P19 embryonal carcinoma cells. Differentiation. 50:1992;57-65.
25. Ridgeway AG, Wilton S, Skerjanc IS: in press. Myocyte enhancer factor 2C and myogenin upregulate each other's expression and induce the development of skeletal muscle in P19 Cells. J Biol Chem.
26. Rossant J., McBurney M.W. The developmental potential of a euploid male teratocarcinoma cell line after blastocyst injection. J Embryol Exp Morphol. 70:1982;99-112.
27. Rudnicki M.A., Jackowski G., Saggin L.et al. Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells. Dev Biol. 138:1990;348-358.
28. Rudnicki MA, McBurney MW: 1987. Cell culture methods and induction of differentiation of embryonal carcinoma cell lines. In Robertson EJ, ed. Teratocarcinomas and Embryonic Stem Cells. A practical approach. Oxford, IRL Press, pp. 19-49.
29. Skerjanc I.S., McBurney M.W. The E box is essential for activity of the cardiac actin promoter in skeletal but not in cardiac muscle. Dev Biol. 163:1994;125-132.
30. Skerjanc I.S., Petropoulos H., Ridgeway A.G.et al. Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 Cells. J Biol Chem. 273:1998;34,904-34,910.
31. Skerjanc I.S., Slack R.S., McBurney M.W. Cellular aggregation enhances MyoD-directed skeletal myogenesis in embryonal carcinoma cells. Mol Cell Biol. 1464:1994;8451-8459.
32. Smith J.C. Mesoderm-inducing factors and mesodermal patterning. Curr Opin Cell Biol. 7:1995;856-861.
33. Smith S.C., Reuhl K.R., Craig J.et al. The role of aggregation in embryonal carcinoma cell differentiation. J Cell Physiol. 131:1987;74-84.
34. Sucov H.M. Molecular insights into cardiac development. Annu Rev Physiol. 60:1998;287-308.
35. Tajbakhsh S., Cossu G. Establishing myogenic identity during somitogenesis. Curr Opin Genet Dev. 7:1997;634-641.
36. Tajbakhsh S., Rocancourt D., Cossu G.et al. Redefining the genetic hierarchies controlling skeletal myogenesis. Pax-3 and Myf-5 act upstream of MyoD Cell. 89:1997;127-138.
37. Vidricaire G., Jardine K., McBurney M.W. Expression of the Brachyury gene during mesoderm development in differentiating embryonal carcinoma cell cultures. Development. 120:1994;115-122.
38. Wilton S., Skerjanc I.S. Factors in serum regulate muscle development in P19 cells. In Vitro Cell Dev Biol Anim. 35:1999;175-177.
39. Wobus A.M., Kleppisch T., Maltsev V.et al. Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels. In Vitro Cell Dev Biol Anim. 30A:1994;425-434.